REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology...

Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today announced that Sangamo scientists and collaborators will present data from the Company's clinical and preclinical...

Audentes Therapeutics, Inc. (Nasdaq: BOLD), a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases,...

With webinars seeing their highest viewing times and driving more leads than ever, there's no better time for marketers to invest in a comprehensive webinar program and strategy. That's why today...

Sustainability initiatives are rapidly changing the transportation industry, with increased focus on major technological advancements to create these opportunities. At the upcoming Advanced Clean...